An Arched Micro-Injector (ARCMI) for innocuous subretinal injection

Yong Sung You, Chang Yeol Lee, Chengguo Li, Sung Ho Lee, Kibom Kim, Hyungil Jung

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Several critical ocular diseases that can lead to blindness are due to retinal disorders. Subretinal drug delivery has been developed recently for the treatment of retinal disorders such as hemorrhage because of the specific ocular structure, namely, the blood retinal barrier (BRB). In the present study, we developed an Arched Micro-injector (ARCMI) for subretinal drug delivery with minimal retinal tissue damage. ARCMIs were fabricated using three major techniques: reverse drawing lithography, controlled air flow, and electroplating. In order to achieve minimal retinal tissue damage, ARCMIs were fabricated with specific features such as a 0.15 mm-1 curvature, 45° tip bevel, 5 mm length, inner diameter of 40 μm, and an outer diameter of 100 μm. These specific features were optimized via in-vitro experiments in artificial ocular hemispherical structures and subretinal injection of indocyanine green in porcine eye ex-vivo. We confirmed that the ARCMI was capable of delivering ocular drugs by subretinal injection without unusual subretinal tissue damage, including hemorrhage.

Original languageEnglish
Article numbere104145
JournalPloS one
Volume9
Issue number8
DOIs
Publication statusPublished - 2014 Aug 11

Fingerprint

injectors
eyes
Tissue
injection
Drug delivery
Injections
Artificial Eye
Blood-Retinal Barrier
drugs
Pharmaceutical Preparations
Electroplating
Hemorrhage
hemorrhage
Indocyanine Green
Eye Diseases
Blindness
eye diseases
Lithography
blindness
Blood

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

You, Yong Sung ; Lee, Chang Yeol ; Li, Chengguo ; Lee, Sung Ho ; Kim, Kibom ; Jung, Hyungil. / An Arched Micro-Injector (ARCMI) for innocuous subretinal injection. In: PloS one. 2014 ; Vol. 9, No. 8.
@article{e26477fd922445d2b0d670a0bab945d8,
title = "An Arched Micro-Injector (ARCMI) for innocuous subretinal injection",
abstract = "Several critical ocular diseases that can lead to blindness are due to retinal disorders. Subretinal drug delivery has been developed recently for the treatment of retinal disorders such as hemorrhage because of the specific ocular structure, namely, the blood retinal barrier (BRB). In the present study, we developed an Arched Micro-injector (ARCMI) for subretinal drug delivery with minimal retinal tissue damage. ARCMIs were fabricated using three major techniques: reverse drawing lithography, controlled air flow, and electroplating. In order to achieve minimal retinal tissue damage, ARCMIs were fabricated with specific features such as a 0.15 mm-1 curvature, 45° tip bevel, 5 mm length, inner diameter of 40 μm, and an outer diameter of 100 μm. These specific features were optimized via in-vitro experiments in artificial ocular hemispherical structures and subretinal injection of indocyanine green in porcine eye ex-vivo. We confirmed that the ARCMI was capable of delivering ocular drugs by subretinal injection without unusual subretinal tissue damage, including hemorrhage.",
author = "You, {Yong Sung} and Lee, {Chang Yeol} and Chengguo Li and Lee, {Sung Ho} and Kibom Kim and Hyungil Jung",
year = "2014",
month = "8",
day = "11",
doi = "10.1371/journal.pone.0104145",
language = "English",
volume = "9",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "8",

}

An Arched Micro-Injector (ARCMI) for innocuous subretinal injection. / You, Yong Sung; Lee, Chang Yeol; Li, Chengguo; Lee, Sung Ho; Kim, Kibom; Jung, Hyungil.

In: PloS one, Vol. 9, No. 8, e104145, 11.08.2014.

Research output: Contribution to journalArticle

TY - JOUR

T1 - An Arched Micro-Injector (ARCMI) for innocuous subretinal injection

AU - You, Yong Sung

AU - Lee, Chang Yeol

AU - Li, Chengguo

AU - Lee, Sung Ho

AU - Kim, Kibom

AU - Jung, Hyungil

PY - 2014/8/11

Y1 - 2014/8/11

N2 - Several critical ocular diseases that can lead to blindness are due to retinal disorders. Subretinal drug delivery has been developed recently for the treatment of retinal disorders such as hemorrhage because of the specific ocular structure, namely, the blood retinal barrier (BRB). In the present study, we developed an Arched Micro-injector (ARCMI) for subretinal drug delivery with minimal retinal tissue damage. ARCMIs were fabricated using three major techniques: reverse drawing lithography, controlled air flow, and electroplating. In order to achieve minimal retinal tissue damage, ARCMIs were fabricated with specific features such as a 0.15 mm-1 curvature, 45° tip bevel, 5 mm length, inner diameter of 40 μm, and an outer diameter of 100 μm. These specific features were optimized via in-vitro experiments in artificial ocular hemispherical structures and subretinal injection of indocyanine green in porcine eye ex-vivo. We confirmed that the ARCMI was capable of delivering ocular drugs by subretinal injection without unusual subretinal tissue damage, including hemorrhage.

AB - Several critical ocular diseases that can lead to blindness are due to retinal disorders. Subretinal drug delivery has been developed recently for the treatment of retinal disorders such as hemorrhage because of the specific ocular structure, namely, the blood retinal barrier (BRB). In the present study, we developed an Arched Micro-injector (ARCMI) for subretinal drug delivery with minimal retinal tissue damage. ARCMIs were fabricated using three major techniques: reverse drawing lithography, controlled air flow, and electroplating. In order to achieve minimal retinal tissue damage, ARCMIs were fabricated with specific features such as a 0.15 mm-1 curvature, 45° tip bevel, 5 mm length, inner diameter of 40 μm, and an outer diameter of 100 μm. These specific features were optimized via in-vitro experiments in artificial ocular hemispherical structures and subretinal injection of indocyanine green in porcine eye ex-vivo. We confirmed that the ARCMI was capable of delivering ocular drugs by subretinal injection without unusual subretinal tissue damage, including hemorrhage.

UR - http://www.scopus.com/inward/record.url?scp=84905845448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905845448&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0104145

DO - 10.1371/journal.pone.0104145

M3 - Article

C2 - 25111562

AN - SCOPUS:84905845448

VL - 9

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 8

M1 - e104145

ER -